Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:2/13/2020)... ... February 13, 2020 , ... President ... year, his budget proposes substantial, damaging cuts to foreign affairs, global health, and ... development and diplomacy, slashes USAID global health programs by $3.1B, and significantly reduces ...
(Date:2/11/2020)... ... February 11, 2020 , ... There are many reasons why Care ... the service that truly raises us above our competitors is our true Peer to ... board-certified Radiologist with years of clinical experience. We understand that it is impossible to ...
(Date:2/11/2020)... ... February 11, 2020 , ... The wait is finally over. The first wild card for ... this squad has been associating professional sports to a truly special project. , The group ... up entirely of athletes with diabetes. They decided to take on the ambitious mission to ...
(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... ... Handbook Revised and Expanded Second Edition: From Sourcing to Butchery, Mindful Meat Eating ... Leigh and published by New Society Publishers, this new version brings discussions of ...
(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is now enrolling for its ... Vegas. The training consists of thread lift placement on real patients for the face, ... lifts represent an excellent alternative currently for nonoperative facelift. The procedures are safe, quick ...
Breaking Medicine News(10 mins):
... There,s little benefit to parents or baby in learning before ... new study suggests. Researchers led by Dr. James Robbins, ... 235 mothers of children aged 2 to 7 years with ... condition was identified before birth (prenatally) in 46 percent of ...
... , FRIDAY, Nov. 26 (HealthDay News) -- Most American ... the topic is far less likely to arise in homes without ... half of American households have a gun, and nearly 30 children ... owned by the child,s family or friends, according to researchers at ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay News) ... and want to keep the weight off, a new Danish ... refined carbohydrates. Based on the findings, the researchers advise ... whole-grain breads. The glycemic index (GI) is a measure of ...
... devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, ... George Washington University, and the International Vaccine Institute (IVI) ... stockpile of cholera vaccines for future humanitarian use. ... maintaining a stockpile of several million doses of cholera ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Nov. 24 ... blood cancers with bone marrow and blood stem cell transplants ... and death, a new study shows. Between the early ... the overall risk of death in an analysis of more ...
... year has brought to light both the promise and ... the most deadly form of skin cancer. Early clinical ... cancer-causing gene revealed impressive results in patients whose cancers ... short-lived, as the tumors invariably returned a few months ...
Cached Medicine News:
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
... Operation: , Standby: A standby switch maintains power to ... : 2 60-ms bursts of 50 Hz separated by ... s (1 pulse/s); 2 Hz (2 pulses/s) , ... pulses/s) , Train-Of-Four: 4 pulses/2 s; repeats every 10 ...
... of Operation: , Standby: A standby switch maintains ... , Twitch: 1 s (1 pulse/s); 2 Hz ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz ... repeats every 10 s , Output Current: Adjustable ...
Medicine Products:
(Date:2/14/2020)... ... February 14, 2020 , ... Group Health Dental , located at 230 ... a complete range of dental services under one roof. The midtown practice has recently ... Find Local Doctors . Find Local Doctors is a trusted online directory that recognizes ...
(Date:2/13/2020)... , ... February 13, 2020 , ... A January ... medically obese and how to combat obesity using a multifaceted approach. Southern California based ... entirely ignore the fact that, when it comes to diet, cutting food intake significantly ...
(Date:2/13/2020)... ... , ... The global market for clinical laboratory services is estimated at $121.5 ... in 2010, according to a new report from Kalorama Information. Kalorama classifies clinical lab ... driven by an aging population and a growing incidence of chronic diseases,” said Bruce ...
Breaking Medicine Technology:
... Boston Scientific Corporation (NYSE: BSX ) today ... Circuit has affirmed the dismissal of a securities fraud case ... Express2 Paclitaxel-Eluting Coronary Stent System in 2004.  The case, ... Retirement System, had previously been dismissed by the U.S. ...
... Aug. 8, 2011 Pharmos Corporation (OTC-PINK: PARS) today reported ... June 30, 2011. These results are included in the Company,s ... the SEC. Second Quarter Ended June 30, ... $0.01 per share, for the second quarter 2011 compared to ...
Cached Medicine Technology: